In CCRCC, loss of TGFBR2 has been reported, which has been associated with tumor progression and also suggested to be the mechanism responsible for the escape from TGF-β-mediated growth repression [10], [11], [12], [13]. The gene discussed is TGFB1; the disease is neoplasm.